World News
-
Mylan and Pfizer announce Viatris as new company name
World | News | 0 Comment | 14 Nov, 2019
Mylan N.V. and Pfizer Inc. have announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris (pro...Read more
-
Merck licenses CRISPR gene-editing technology to Evotec
World | News | 0 Comment | 13 Nov, 2019
Merck, a leading science and technology company, has announced that it has signed a license agreement providing Evotec SE access to Merck's foundational CRISPR intellectual proper...Read more
-
Vygon Group joins forces with EFCNI
World | News | 0 Comment | 12 Nov, 2019
France based Vygon Group, a specialist single-use medical devices group, is organizing a number of awareness events in hospitals worldwide for World Prematurity Day on November 17. Vygon is...Read more
-
Abbott discovers new strain of HIV
World | News | 0 Comment | 08 Nov, 2019
Abbott has announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L. The findings, published in the&n...Read more
-
PromoCell now offers in vitro disease models
World | News | 0 Comment | 07 Nov, 2019
PromoCell, a Germany based premier manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes type 1 ...Read more
-
Merck introduces fast-dissolving material for immediate release coating
World | News | 0 Comment | 06 Nov, 2019
Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engine...Read more
-
Merck launches nanoparticle-reduced sucrose for biopharma formulations
World | News | 0 Comment | 07 Nov, 2019
Merck has developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with reduced levels of nanoparticle impurities (NPI). The new product, Suc...Read more
-
Thermo Fisher to invest $24M for bioproduction expansion
World | News | 0 Comment | 06 Nov, 2019
Thermo Fisher Scientific, the world leader in serving science, has announced that it is investing nearly $24 million in its Inchinnan, Scotland, site to expand global bioprod...Read more
-
SCBIO 2019 awards recognizes profound contributions to life sciences industry
World | News | 0 Comment | 05 Nov, 2019
To resounding applause from a record gathering from 11 countries, 32 states and virtually every county in South Carolina, life sciences leaders at SCBIO 2019 in Greenville saluted...Read more
-
Cerecin strengthens its leadership position in CNS drug development
World | News | 0 Comment | 05 Nov, 2019
Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world, on 4 Nov 2019, announced the appointment of Bruce Mori...Read more
-
FDA approves Sanofi’s Influenza Vaccine for older people
World | News | 0 Comment | 05 Nov, 2019
The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 y...Read more
-
Shimmer Receives CE Certification for ECGmd Holter Monitor Electrocardiograph
World | News | 0 Comment | 05 Nov, 2019
Shimmer Research, a global leader in wearable technology for research applications, on 4 Nov 2019, announced that ECGmd – its five-wire, four-lead holter monitor electrocard...Read more
-
Boehringer Ingelheim and Lilly modernise alliance
World | News | 0 Comment | 05 Nov, 2019
In a move to better serve people living with and without diabetes, Boehringer Ingelheim and Eli Lilly and Company will modernise their current alliance as of 1 January 2020 and fo...Read more
-
World | News | 0 Comment | 31 Oct, 2019
For the first time, scientists at Newcastle University have found there are at least four versions of primary Sjögren's syndrome (PSS)- a chronic inflammatory disease that affects the ...Read more
-
Pear Therapeutics collaborates with Ironwood Pharma for GI-focused digital therapeutics
World | News | 0 Comment | 31 Oct, 2019
Pear Therapeutics, Inc. announced that it has entered into an agreement with Ironwood Pharmaceuticals, Inc. to evaluate Prescription Digital Therapeutics (PDTs) for the treatment of selecte...Read more
-
AstraZeneca divests rights to Seroquel, Seroquel XR in Europe, Russia
World | News | 0 Comment | 31 Oct, 2019
AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended re...Read more
-
80% of Global Bone Marrow Transplantation Demand is by EU and NA
World | News | 0 Comment | 30 Oct, 2019
In addition to a rapid expansion of bone marrow donor registry, increasing commercialization of cellular therapy and tissue engineering increased survival rate post bone marrow transplant p...Read more
-
EU approves BAVENCIO® (avelumab) Plus Axitinib to treat RCC
World | News | 0 Comment | 29 Oct, 2019
Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of adu...Read more
